E Fund (HK) Solactive Biopharma Select Index ETF (03186.HK) Rises 6.00% to HKD 15.550
Newtimespace News: As of 14:12 on August 20, E Fund (HK) Solactive Biopharma Select Index ETF (03186.HK) stood at HKD 15.550, up 6.00%. The ETF opened at HKD 15.000, with the latest net asset value (NAV) at HKD 15.027, a discount of 2.38%, a 52-week high of HKD 16.950, a 52-week low of HKD 12.710, a turnover of approximately HKD 4.2454 million, and assets under management of approximately HKD 25.55 million.
E Fund (HK) Solactive Biopharma Select Index ETF (03186.HK) tracks the Solactive Biopharma Select Index, with constituent stocks primarily concentrated in the innovative drug sector, covering frontier therapeutic areas such as metabolic disorders (including weight loss), oncology, and immunology.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- E Fund Biopharma(03186.HK) up 1.47%, China out-licensing tops $120bn
- E Fund (HK) Solactive Biopharma Select Index ETF (03186.HK) Rises 2.24% to HKD 14.600
- E Fund (HK) Solactive Biopharma Select Index ETF (03186.HK) Rises 0.74%, NAV at HKD 14.978
- HK shares ETFs Daily Report : Biotech & High-Dividend ETFs Edge Higher Modestly, Leveraged ChiNext, Korea and Taiwan ETFs Plunge - 20260902
- HK shares ETFs Daily Report: Gold Miners Extend Gains 5.7%! Blockchain and Korea Counterattack in Tandem, Biomedicine and MedTech Lead Declines - 20260821